文献速递糖尿病

西格列汀对成人隐匿性自身免疫糖尿病胰岛功能与胰岛素敏感性的随机试验

Islet Function and Insulin Sensitivity in Latent Autoimmune Diabetes in Adults Taking Sitagliptin: A Randomized Trial.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

结果显示西格列汀组β细胞功能无显著变化,而对照组2小时C肽及ΔC肽下降;西格列汀组HOMA2-B变化更大,且高糖钳夹第一时相胰岛素分泌及高胰岛素正葡萄糖钳夹的胰岛素敏感性指标优于对照组。

要点

  • 西格列汀联合胰岛素可维持LADA患者24个月β细胞功能。
  • 单用胰岛素组24个月时2小时C肽及ΔC肽下降。
  • 西格列汀组胰岛素敏感性指标较高胰岛素正葡萄糖钳夹改善。

核心结论

  • 与单用胰岛素相比,西格列汀联合胰岛素治疗在一定程度上维持LADA患者β细胞功能并改善胰岛素敏感性。

主要发现

  • 24个月随访期间,西格列汀组β细胞功能无显著变化,而对照组24个月时2小时餐后C肽(2hCP)及ΔC肽(2hCP-FCP)水平降低。
  • 西格列汀组HOMA2-B自基线的变化大于对照组。
  • 24个月时高糖钳夹显示西格列汀组第一时相胰岛素分泌改善且高于对照组(P < .001)。
  • 高胰岛素正葡萄糖钳夹中,西格列汀组葡萄糖代谢率(M)、胰岛素敏感性指数及M与对数胰岛素比值均较基线升高(均P < .01 vs 基线),且高于对照组。

临床怎么用

  • 对于接受胰岛素治疗的LADA患者,可考虑联合西格列汀以维持β细胞功能并改善胰岛素敏感性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The long-term effects of dipeptidyl peptidase-4 inhibitors on β-cell function and insulin sensitivity in latent autoimmune diabetes in adults (LADA) are unclear. OBJECTIVE: To investigate the effects of sitagliptin on β-cell function and insulin sensitivity in LADA patients receiving insulin. DESIGN AND SETTING: A randomized controlled trial at the Second Xiangya Hospital. METHODS: Fifty-one patients with LADA were randomized to sitagliptin + insulin (SITA) group or insulin alone (CONT) group for 24 months. MAIN OUTCOME MEASURES: Fasting C-peptide (FCP), 2-hour postprandial C-peptide (2hCP) during mixed-meal tolerance test, △CP (2hCP - FCP), and updated homeostatic model assessment of β-cell function (HOMA2-B) were determined every 6 months. In 12 subjects, hyperglycemic clamp and hyperinsulinemic euglycemic clamp (HEC) tests were further conducted at 12-month intervals. RESULTS: During the 24-month follow-up, there were no significant changes in β-cell function in the SITA group, whereas the levels of 2hCP and △CP in the CONT group were reduced at 24 months. Meanwhile, the changes in HOMA2-B from baseline were larger in the SITA group than in the CONT group. At 24 months, first-phase insulin secretion was improved in the SITA group by hyperglycemia clamp, which was higher than in the CONT group (P < .001), while glucose metabolized (M), insulin sensitivity index, and M over logarithmical insulin ratio in HEC were increased in the SITA group (all P < .01 vs baseline), which were higher than in the CONT group. CONCLUSION: Compared with insulin intervention alone, sitagliptin plus insulin treatment appeared to maintain β-cell function and improve insulin sensitivity in LADA to some extent.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Yang L, Liang H, Liu X, et al. Islet Function and Insulin Sensitivity in Latent Autoimmune Diabetes in Adults Taking Sitagliptin: A Randomized Trial. J Clin Endocrinol Metab. 2021. PMID: 33475138. doi:10.1210/clinem/dgab026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。